Nurse practitioner prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D. The State Board of Pharmacy - ANSWER-C. The State Board of Nursing for each
state
Physician Assistant (PA) prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing
D. The State Board of Medical Examiners - ANSWER-D. The State Board of Medical
Examiners
Clinical judgment in prescribing includes:
A. Factoring in the cost to the patient of the medication prescribed
B. Always prescribing the newest medication available for the disease process C.
Handing out drug samples to poor patients
D. Prescribing all generic medications to cut costs - ANSWER-A. Factoring in the cost to
the patient of the medication prescribed
Criteria for choosing an effective drug for a disorder include:
A. Asking the patient what drug they think would work best for them
B. Consulting nationally recognized guidelines for disease management
C. Prescribing medications that are available as samples before writing a prescription
,D. Following U.S. Drug Enforcement Administration (DEA) guidelines for prescribing -
ANSWER-B. Consulting nationally recognized guidelines for disease management
Nurse practitioner practice may thrive under health-care reform due to:
A. The demonstrated ability of nurse practitioners to control costs and improve patient
outcomes
B. The fact that nurse practitioners will be able to practice independently
C. The fact that nurse practitioners will have full reimbursement under health-care
reform
D. The ability to shift accountability for Medicaid to the state level - ANSWER-A. The
demonstrated ability of nurse practitioners to control costs and improve patient
outcomes
A patient's nutritional intake and lab work reflects hypoalbuminemia. This is critical to
prescribing because:
A. Distribution of drugs to target tissue may be affected
B. The solubility of the drug will not match the site of absorption
C. There will be less free drug available to generate an effect
D. Drugs bound to albumin are readily excreted by the kidney - ANSWER-A. Distribution
of drugs to target tissue may be affected
Drugs that have a significant first-pass effect: A. Must be given by the enteral (oral)
route only
B. Bypass the hepatic circulation
C. Are rapidly metabolized by the liver and may have little if any desired action
D. Are converted by the liver to more active and fat-soluble forms - ANSWER-C. Are
rapidly metabolized by the liver and may have little if any desired action
The route of excretion of a volatile drug will likely be:
A. The kidneys
B. The lungs
C. The bile and feces
D. The skin - ANSWER-B. The lungs
Medroxyprogesterone (Depo Provera) is prescribed IM to create a storage reservoir of
the drug. Storage reservoirs:
A. Assure that the drug will reach its intended target tissue
B. Are the reason for giving loading doses
C. Increase the length of time a drug is available and active
D. Are most common in collagen tissues - ANSWER-C. Increase the length of time a
drug is available and active
The NP chooses to give cephalexin every 8 hours based on knowledge of the drug's:
A. Propensity to go to the target receptor
B. Biological half-life
C. Pharmacodynamics
D. Safety and side effects - ANSWER-B. Biological half-life
Azithromycin dosing requires the first day's dose be twice those of the other 4 days of
the prescription. This is considered a loading dose. A loading dose: A. Rapidly achieves
drug levels in the therapeutic range
B. Requires four to five half-lives to attain
C. Is influenced by renal function
, D. Is directly related to the drug circulating to the target tissues - ANSWER-A. Rapidly
achieves drug levels in the therapeutic range
The point in time on the drug concentration curve that indicates the first sign of a
therapeutic effect is the:
A. Minimum adverse effect level
B. Peak of action
C. Onset of action
D. Therapeutic range - ANSWER-C. Onset of action
Phenytoin requires a trough level be drawn. Peak and trough levels are done: A. When
the drug has a wide therapeutic range
B. When the drug will be administered for a short time only
C. When there is a high correlation between the dose and saturation of receptor sites
D. To determine if a drug is in the therapeutic range - ANSWER-D. To determine if a
drug is in the therapeutic range
A laboratory result indicates the peak level for a drug is above the minimum toxic
concentration. This means that the:
A. Concentration will produce therapeutic effects
B. Concentration will produce an adverse response
C. Time between doses must be shortened
D. Duration of action of the drug is too long - ANSWER-B. Concentration will produce an
adverse response
Drugs that are receptor agonists may demonstrate what property?
A. Irreversible binding to the drug receptor site
B. Up-regulation with chronic use
C. Desensitization or down-regulation with continuous use
D. Inverse relationship between drug concentration and drug action - ANSWER-C.
Desensitization or down-regulation with continuous use
Drugs that are receptor antagonists, such as beta blockers, may cause:
A. Down-regulation of the drug receptor
B. An exaggerated response if abruptly discontinued
C. Partial blockade of the effects of agonist drugs
D. An exaggerated response to competitive drug agonists - ANSWER-B. An exaggerated
response if abruptly discontinued
Factors that affect gastric drug absorption include:
A. Liver enzyme activity
B. Protein-binding properties of the drug molecule
C. Lipid solubility of the drug
D. Ability to chew and swallow - ANSWER-C. Lipid solubility of the drug
Drugs administered via intravenous (IV) route:
A. Need to be lipid soluble in order to be easily absorbed
B. Begin distribution into the body immediately
C. Are easily absorbed if they are nonionized
D. May use pinocytosis to be absorbed - ANSWER-B. Begin distribution into the body
immediately
When a medication is added to a regimen for a synergistic effect, the combined effect of
the drugs is:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D. The State Board of Pharmacy - ANSWER-C. The State Board of Nursing for each
state
Physician Assistant (PA) prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing
D. The State Board of Medical Examiners - ANSWER-D. The State Board of Medical
Examiners
Clinical judgment in prescribing includes:
A. Factoring in the cost to the patient of the medication prescribed
B. Always prescribing the newest medication available for the disease process C.
Handing out drug samples to poor patients
D. Prescribing all generic medications to cut costs - ANSWER-A. Factoring in the cost to
the patient of the medication prescribed
Criteria for choosing an effective drug for a disorder include:
A. Asking the patient what drug they think would work best for them
B. Consulting nationally recognized guidelines for disease management
C. Prescribing medications that are available as samples before writing a prescription
,D. Following U.S. Drug Enforcement Administration (DEA) guidelines for prescribing -
ANSWER-B. Consulting nationally recognized guidelines for disease management
Nurse practitioner practice may thrive under health-care reform due to:
A. The demonstrated ability of nurse practitioners to control costs and improve patient
outcomes
B. The fact that nurse practitioners will be able to practice independently
C. The fact that nurse practitioners will have full reimbursement under health-care
reform
D. The ability to shift accountability for Medicaid to the state level - ANSWER-A. The
demonstrated ability of nurse practitioners to control costs and improve patient
outcomes
A patient's nutritional intake and lab work reflects hypoalbuminemia. This is critical to
prescribing because:
A. Distribution of drugs to target tissue may be affected
B. The solubility of the drug will not match the site of absorption
C. There will be less free drug available to generate an effect
D. Drugs bound to albumin are readily excreted by the kidney - ANSWER-A. Distribution
of drugs to target tissue may be affected
Drugs that have a significant first-pass effect: A. Must be given by the enteral (oral)
route only
B. Bypass the hepatic circulation
C. Are rapidly metabolized by the liver and may have little if any desired action
D. Are converted by the liver to more active and fat-soluble forms - ANSWER-C. Are
rapidly metabolized by the liver and may have little if any desired action
The route of excretion of a volatile drug will likely be:
A. The kidneys
B. The lungs
C. The bile and feces
D. The skin - ANSWER-B. The lungs
Medroxyprogesterone (Depo Provera) is prescribed IM to create a storage reservoir of
the drug. Storage reservoirs:
A. Assure that the drug will reach its intended target tissue
B. Are the reason for giving loading doses
C. Increase the length of time a drug is available and active
D. Are most common in collagen tissues - ANSWER-C. Increase the length of time a
drug is available and active
The NP chooses to give cephalexin every 8 hours based on knowledge of the drug's:
A. Propensity to go to the target receptor
B. Biological half-life
C. Pharmacodynamics
D. Safety and side effects - ANSWER-B. Biological half-life
Azithromycin dosing requires the first day's dose be twice those of the other 4 days of
the prescription. This is considered a loading dose. A loading dose: A. Rapidly achieves
drug levels in the therapeutic range
B. Requires four to five half-lives to attain
C. Is influenced by renal function
, D. Is directly related to the drug circulating to the target tissues - ANSWER-A. Rapidly
achieves drug levels in the therapeutic range
The point in time on the drug concentration curve that indicates the first sign of a
therapeutic effect is the:
A. Minimum adverse effect level
B. Peak of action
C. Onset of action
D. Therapeutic range - ANSWER-C. Onset of action
Phenytoin requires a trough level be drawn. Peak and trough levels are done: A. When
the drug has a wide therapeutic range
B. When the drug will be administered for a short time only
C. When there is a high correlation between the dose and saturation of receptor sites
D. To determine if a drug is in the therapeutic range - ANSWER-D. To determine if a
drug is in the therapeutic range
A laboratory result indicates the peak level for a drug is above the minimum toxic
concentration. This means that the:
A. Concentration will produce therapeutic effects
B. Concentration will produce an adverse response
C. Time between doses must be shortened
D. Duration of action of the drug is too long - ANSWER-B. Concentration will produce an
adverse response
Drugs that are receptor agonists may demonstrate what property?
A. Irreversible binding to the drug receptor site
B. Up-regulation with chronic use
C. Desensitization or down-regulation with continuous use
D. Inverse relationship between drug concentration and drug action - ANSWER-C.
Desensitization or down-regulation with continuous use
Drugs that are receptor antagonists, such as beta blockers, may cause:
A. Down-regulation of the drug receptor
B. An exaggerated response if abruptly discontinued
C. Partial blockade of the effects of agonist drugs
D. An exaggerated response to competitive drug agonists - ANSWER-B. An exaggerated
response if abruptly discontinued
Factors that affect gastric drug absorption include:
A. Liver enzyme activity
B. Protein-binding properties of the drug molecule
C. Lipid solubility of the drug
D. Ability to chew and swallow - ANSWER-C. Lipid solubility of the drug
Drugs administered via intravenous (IV) route:
A. Need to be lipid soluble in order to be easily absorbed
B. Begin distribution into the body immediately
C. Are easily absorbed if they are nonionized
D. May use pinocytosis to be absorbed - ANSWER-B. Begin distribution into the body
immediately
When a medication is added to a regimen for a synergistic effect, the combined effect of
the drugs is:
